Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 233

1.

The Lim1 oncogene as a new therapeutic target for metastatic human renal cell carcinoma.

Hamaidi I, Coquard C, Danilin S, Dormoy V, Béraud C, Rothhut S, Barthelmebs M, Benkirane-Jessel N, Lindner V, Lang H, Massfelder T.

Oncogene. 2018 Aug 3. doi: 10.1038/s41388-018-0413-y. [Epub ahead of print]

PMID:
30076415
2.

An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers.

Mahe M, Dufour F, Neyret-Kahn H, Moreno-Vega A, Beraud C, Shi M, Hamaidi I, Sanchez-Quiles V, Krucker C, Dorland-Galliot M, Chapeaublanc E, Nicolle R, Lang H, Pouponnot C, Massfelder T, Radvanyi F, Bernard-Pierrot I.

EMBO Mol Med. 2018 Apr;10(4). pii: e8163. doi: 10.15252/emmm.201708163.

3.

Reassessment of the capacity of the HIV-1 Env cytoplasmic domain to trigger NF-κB activation.

Beraud C, Lemaire M, Perez Bercoff D.

Virol J. 2018 Feb 17;15(1):35. doi: 10.1186/s12985-018-0941-7.

4.

Parathyroid Hormone-Related Protein Contributes to Early Healing of Habu Snake Venom-Induced Glomerulonephritis in Mice.

Hochane M, Raison D, Coquard C, Béraud C, Danilin S, Bethry A, Massfelder T, Barthelmebs M.

Am J Pathol. 2018 Apr;188(4):863-875. doi: 10.1016/j.ajpath.2017.12.012. Epub 2018 Jan 17.

PMID:
29353060
5.

Parathyroid hormone-related protein modulates inflammation in mouse mesangial cells and blunts apoptosis by enhancing COX-2 expression.

Hochane M, Raison D, Coquard C, Béraud C, Bethry A, Danilin S, Massfelder T, Barthelmebs M.

Am J Physiol Cell Physiol. 2018 Feb 1;314(2):C242-C253. doi: 10.1152/ajpcell.00018.2017. Epub 2017 Nov 15.

PMID:
29141920
6.

The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell Transmission.

Santos da Silva E, Mulinge M, Lemaire M, Masquelier C, Beraud C, Rybicki A, Servais JY, Iserentant G, Schmit JC, Seguin-Devaux C, Perez Bercoff D.

PLoS One. 2016 Sep 6;11(9):e0161596. doi: 10.1371/journal.pone.0161596. eCollection 2016.

7.

Establishment of a large panel of patient-derived preclinical models of human renal cell carcinoma.

Lang H, Béraud C, Bethry A, Danilin S, Lindner V, Coquard C, Rothhut S, Massfelder T.

Oncotarget. 2016 Sep 13;7(37):59336-59359. doi: 10.18632/oncotarget.10659.

8.

Targeting FAK scaffold functions inhibits human renal cell carcinoma growth.

Béraud C, Dormoy V, Danilin S, Lindner V, Béthry A, Hochane M, Coquard C, Barthelmebs M, Jacqmin D, Lang H, Massfelder T.

Int J Cancer. 2015 Oct 1;137(7):1549-59. doi: 10.1002/ijc.29522. Epub 2015 Apr 9.

9.

Elvitegravir/cobicistat/emtricitabine/tenofovir DF in HIV-infected patients with mild-to-moderate renal impairment.

Post FA, Winston J, Andrade-Villanueva JF, Fisher M, Liu Y, Beraud C, Abram ME, Graham H, Rhee MS, Cheng AK, Szwarcberg J; Study 118 Team.

J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):310-3. doi: 10.1097/QAI.0000000000000476.

PMID:
25469527
10.

Eukaryotic GPN-loop GTPases paralogs use a dimeric assembly reminiscent of archeal GPN.

Alonso B, Beraud C, Meguellati S, Chen SW, Pellequer JL, Armengaud J, Godon C.

Cell Cycle. 2013 Feb 1;12(3):463-72. doi: 10.4161/cc.23367. Epub 2013 Jan 16.

11.

Vitamin D3 triggers antitumor activity through targeting hedgehog signaling in human renal cell carcinoma.

Dormoy V, Béraud C, Lindner V, Coquard C, Barthelmebs M, Brasse D, Jacqmin D, Lang H, Massfelder T.

Carcinogenesis. 2012 Nov;33(11):2084-93. doi: 10.1093/carcin/bgs255. Epub 2012 Jul 28.

PMID:
22843547
12.

Spt6 levels are modulated by PAAF1 and proteasome to regulate the HIV-1 LTR.

Nakamura M, Basavarajaiah P, Rousset E, Beraud C, Latreille D, Henaoui IS, Lassot I, Mari B, Kiernan R.

Retrovirology. 2012 Feb 8;9:13. doi: 10.1186/1742-4690-9-13.

13.

LIM-class homeobox gene Lim1, a novel oncogene in human renal cell carcinoma.

Dormoy V, Béraud C, Lindner V, Thomas L, Coquard C, Barthelmebs M, Jacqmin D, Lang H, Massfelder T.

Oncogene. 2011 Apr 14;30(15):1753-63. doi: 10.1038/onc.2010.557. Epub 2010 Dec 6.

PMID:
21132009
14.

Differential regulation of WASP and N-WASP by Cdc42, Rac1, Nck, and PI(4,5)P2.

Tomasevic N, Jia Z, Russell A, Fujii T, Hartman JJ, Clancy S, Wang M, Beraud C, Wood KW, Sakowicz R.

Biochemistry. 2007 Mar 20;46(11):3494-502. Epub 2007 Feb 16.

PMID:
17302440
15.

Antitumor activity of a kinesin inhibitor.

Sakowicz R, Finer JT, Beraud C, Crompton A, Lewis E, Fritsch A, Lee Y, Mak J, Moody R, Turincio R, Chabala JC, Gonzales P, Roth S, Weitman S, Wood KW.

Cancer Res. 2004 May 1;64(9):3276-80.

16.

A mechanism for microtubule depolymerization by KinI kinesins.

Moores CA, Yu M, Guo J, Beraud C, Sakowicz R, Milligan RA.

Mol Cell. 2002 Apr;9(4):903-9.

17.

Crystal structure of the mitotic spindle kinesin Eg5 reveals a novel conformation of the neck-linker.

Turner J, Anderson R, Guo J, Beraud C, Fletterick R, Sakowicz R.

J Biol Chem. 2001 Jul 6;276(27):25496-502. Epub 2001 Apr 27.

18.

Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation.

Béraud C, Henzel WJ, Baeuerle PA.

Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):429-34.

19.

[Patients' needs and quality of care].

Béraud C.

Rev Epidemiol Sante Publique. 1998 Nov;46(5):345-9. French. No abstract available.

PMID:
9864763
20.

Interaction of HTLV-I Tax with the human proteasome: implications for NF-kappa B induction.

Béraud C, Greene WC.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S76-84. Review.

PMID:
8797708
22.

Autoregulation of the NF-kappa B transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs.

Sun SC, Ganchi PA, Béraud C, Ballard DW, Greene WC.

Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1346-50.

23.
24.

Functional and biochemical interaction of the HTLV-I Tax1 transactivator with TBP.

Caron C, Rousset R, Béraud C, Moncollin V, Egly JM, Jalinot P.

EMBO J. 1993 Nov;12(11):4269-78.

25.
26.

Medical audit in France: from ideal to reality.

Amouretti M, Beraud C, Saint-Martin E.

BMJ. 1992 Feb 15;304(6824):428-30. No abstract available.

27.
28.

Lichen amyloidosis in Alagille syndrome.

Doutre MS, Beylot C, Couzigou P, Beraud C.

Arch Dermatol. 1991 Oct;127(10):1590-1. No abstract available.

PMID:
1929477
29.

Tax1 induction of the HTLV-I 21 bp enhancer requires cooperation between two cellular DNA-binding proteins.

Montagne J, Béraud C, Crenon I, Lombard-Platet G, Gazzolo L, Sergeant A, Jalinot P.

EMBO J. 1990 Mar;9(3):957-64.

30.

[Evaluation of decontamination procedures used at digestive endoscopy units in Gironde].

Raymond JM, Labadie JC, Fayon E, Bui F, Baldit C, Dumas F, Couzigou P, Béraud C, Amouretti M.

Gastroenterol Clin Biol. 1990;14(2):134-9. French.

PMID:
2328880
31.

Fatal acute hepatitis due to amodiaquine.

Raymond JM, Dumas F, Baldit C, Couzigou P, Beraud C, Amouretti M.

J Clin Gastroenterol. 1989 Oct;11(5):602-3. No abstract available.

PMID:
2794450
32.

[Asymptomatic Caroli's disease limited to the left hepatic lobe. A cause of isolated increase of gammaglutamyltranspeptidase?].

Raymond JM, Amouretti M, Dumas F, Baldit C, Couzigou P, Beraud C.

Presse Med. 1989 Jan 21;18(2):79. French. No abstract available.

PMID:
2563587
33.

Ethanol-cimetidine interaction.

Baldit C, Couzigou P, Fleury B, Dumas F, Raymond JM, Amouretti M, Beraud C.

Am J Gastroenterol. 1988 Jun;83(6):700. No abstract available.

PMID:
3376929
34.

Vanadium and sodium retention in cirrhosis.

Couzigou P, Fleury B, Lucena-Flores A, Baldit C, Dumas F, Raymand JM, Amouretti M, Beraud C, Simonoff M.

Am J Gastroenterol. 1988 Feb;83(2):204-5. No abstract available.

PMID:
3341348
35.

[Alcoholics, hepato-gastroenterologists and psychotherapists].

Béraud C, Fleury B.

Gastroenterol Clin Biol. 1987 Dec;11(12):845-8. French. No abstract available.

PMID:
3449402
36.

[Amodiaquine (Flavoquine) is hepatotoxic].

Amouretti M, Raymond JM, Baldit C, Dumas F, Couzigou P, Béraud C.

Gastroenterol Clin Biol. 1986 Dec;10(12):855. French. No abstract available.

PMID:
3803831
37.

[Is alcoholism a disease?].

Béraud C, Fleury B.

Gastroenterol Clin Biol. 1986 Jun-Jul;10(6-7):457-60. French. No abstract available.

PMID:
3758589
38.

[Congenital hepatic fibrosis disclosed late by hepatic encephalopathy].

Richard-Molard B, Couzigou P, Julien J, Amouretti M, Béraud C.

Gastroenterol Clin Biol. 1985 May;9(5):449-51. French.

PMID:
4007391
39.

[Changes in circulating lymphocyte subsets in alcoholic hepatopathies. Respective role of alcohol, hepatocellular insufficiency and malnutrition].

Couzigou P, Vincendeau P, Fleury B, Richard-Molard B, Pierron A, Bergeron JL, Bezian JH, Amouretti M, Béraud C.

Gastroenterol Clin Biol. 1984 Dec;8(12):915-9. French.

PMID:
6519399
40.

[The mouth and life: risks and limitations of alcoholic abstinence].

Béraud C, Fleury B.

Gastroenterol Clin Biol. 1984 Oct;8(10):699-701. French. No abstract available.

PMID:
6526224
41.

[Evolution of serum gammaglutamyl transpeptidase activity in treated hyperthyroid and hypothyroid patients].

Couzigou P, Latapie JL, Fleury B, Climas MT, Le Moigne F, Crockett E, Sauneron MF, Richard-Molard B, Amouretti M, Béraud C.

Gastroenterol Clin Biol. 1984 May;8(5):458-63. French.

PMID:
6145651
42.

[Pharmacokinetics of alcohol after 3-hour intravenous infusion with and without cimetidine in 10 healthy non-alcoholic subjects].

Couzigou P, Fleury B, Bourjac M, Betbeder AM, Vinçon G, Richard-Molard B, Albin H, Amouretti M, Béraud C.

Gastroenterol Clin Biol. 1984 Feb;8(2):103-8. French.

PMID:
6698348
43.

[Chronic vomiting disclosing pheochromocytoma].

Couzigou P, Richard-Molard B, Fleury B, Cazenave P, Amouretti M, Béraud C.

Gastroenterol Clin Biol. 1984 Jan;8(1):88-9. French. No abstract available.

PMID:
6698346
44.

High density lipoprotein cholesterol and apoprotein A1 in healthy volunteers during long-term moderate alcohol intake.

Couzigou P, Fleury B, Crockett R, Rautou JJ, Blanchard P, Lemoine F, Richard-Molard B, Amouretti M, Béraud C.

Ann Nutr Metab. 1984;28(6):377-84.

PMID:
6595959
45.

[Chronic vomiting disclosing a pheochromocytoma].

Couzigou P, Richard Molard B, Fleury B, Cazenave P, Eresue J, Philippe JC, Drouillard J, Amouretti M, Beraud C.

Sem Hop. 1983 Nov 3;59(40):2781-3. French.

PMID:
6316536
46.

[Thalidomide and the treatment of Behçet's syndrome].

Couzigou P, Doutre MS, Houdée G, Richard-Molard B, Fleury B, Amouretti M, Beylot C, Béraud C.

Gastroenterol Clin Biol. 1983 Aug-Sep;7(8-9):751. French. No abstract available.

PMID:
6618080
47.

[Pharmacokinetics of cimetidine in ascitic cirrhotics].

Albin H, Couzigou P, Vinçon G, Péhourcq F, Fleury B, Béraud C.

Gastroenterol Clin Biol. 1983 Mar;7(3):251-5. French.

PMID:
6852412
48.

[Necrotizing enterocolitis associated with agranulocytosis are major forms of pseudomembranous colitis (author's transl)].

Couzigou P, Reiffers J, Levéque AM, Amouretti M, Broustet A, Béraud C.

Gastroenterol Clin Biol. 1982 Jan;6(1):48-51. French. No abstract available.

PMID:
7067949
49.

[Biliary scintigraphy: actual innovation or nuclear gadget?].

Béraud C, Couzigou P.

Gastroenterol Clin Biol. 1981 Apr;5(4):365-9. French. No abstract available.

PMID:
7227745
50.

More on Whipple's disease.

Vincendeau P, Bezian JH, Couzigou P, Amouretti M, Leveque AM, Beraud C.

Gastroenterology. 1981 Apr;80(4):878-9. No abstract available.

PMID:
6162708

Supplemental Content

Loading ...
Support Center